HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

4th Edition of Global Conference on Gynecology & Women's Health

September 28-30, 2026 | London, UK

Gynec 2026

Pathologic findings in women with atypical glandular cells on Pap test

Speaker at Gynecology Conferences - Neda Zarrin-Khameh
Baylor College of Medicine, United States
Title : Pathologic findings in women with atypical glandular cells on Pap test

Abstract:

Introduction: It has been shown that a significant subset of atypical glandular cells (AGC) indicates underlying malignancies. Therefore, it is imperative to recognize, diagnose, and treat these lesions early. We evaluated the clinical significance of AGC on cervical cytology in our hospital.

Materials and methods: A total of 376 consecutive Pap tests with a diagnosis of AGC between January 2005 and January 2011 at a tertiary community hospital were reviewed and correlated with concurrent or follow-up histopathology.

Results: Over a 6-year period 376 (0.23%) Pap tests were reported as AGC. Histopathology was available in 223 cases. Atypical hyperplasia, dysplasia, or malignant lesion was found in 128 (57.4%) cases. Of these, 80 (62.5%) were glandular lesions. In women younger than 48 years benign lesions (52.9%) were more common. Women who were 48 years and older were more likely to have a malignant glandular lesion (56 out of 73, 76.7%) compared with women under 48 years, who were more likely to have a malignant squamous lesion (31 out of 55, 56.4%). This difference was statistically significant (P = 0.002). Malignant lesion was seen in 58 (26%) of the women. Endometrial carcinoma (30 cases) was the most common malignancy-51.7% of the malignant lesions and 13.4% overall. Chronic cervicitis and endometritis were the most common non-malignant findings.

Conclusion: AGC on Pap test may be the initial manifestation of a wide range of cervical pathologies. Because many AGC diagnoses did not have a histopathological follow-up, clinicans should be more diligent at having patients follow up, especially in peri- and post-menopausal women.

Biography:

Neda Zarrin-Khameh, MD, MPH is a Professor of Pathology & Immunology at Baylor College of Medicine. She is Director of the Baylor Cytopathology Fellowship and Medical Director of Ben Taub Anatomic Pathology. She received her MD from Tehran University of Medical Sciences in Tehran/Iran and received her Masters of Public Health from the University of Texas at Houston. She completed her Pathology Residency at Baylor College of Medicine.  She received the inaugural “Resident Good Citizen Award”, based upon her helpfulness to her resident colleagues. She completed a Cytopathology Fellowship at Baylor College of Medicine and a Surgical Pathology Fellowship at Houston Methodist Hospital. Since becoming faculty at Ben Taub Hospital, she has received “Faculty Award for Outstanding Resident Teaching Anatomic Pathology” three times. She also received Norton Rose Fulbright Award, Star Award for Excellence in Patient Care and Women of Excellence award.  Although she enjoys all areas of pathology, she has particular interest in GI, Gyn, soft tissue and cytology. She is passionate about teaching. She has published multiple papers and is involved in multiple transitional research projects, some collaborative with other clinicians. She is the co-chair of cytopathology committee for American Society of Clinical Pathology.

Watsapp